Connection
Laura Ramsey to Antipsychotic Agents
This is a "connection" page, showing publications Laura Ramsey has written about Antipsychotic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.092 |
|
|
|
-
Kanu AA, Johnston MM, Poweleit EA, Vaughn SE, Strawn JR, Ramsey LB. Influence of CYP2D6 Metabolizer Status on Risperidone and Paliperidone Tolerability in Children and Adolescents. J Child Adolesc Psychopharmacol. 2024 02; 34(1):34-41.
Score: 0.918
-
Rossow KM, Vaughn SE, Strawn JR, Van Driest SL, Ramsey LB. The need for a refined understanding of CYP2D6 in second-generation antipsychotic outcomes in children and adolescents. Pharmacogenomics. 2021 06; 22(8):447-450.
Score: 0.762
-
Jallaq SA, Verba M, Strawn JR, Martin LJ, DelBello MP, Ramsey LB. CYP2D6 Phenotype Influences Aripiprazole Tolerability in Pediatric Patients with Mood Disorders. J Child Adolesc Psychopharmacol. 2021 02; 31(1):56-62.
Score: 0.723
-
Poweleit EA, Colestock M, Kantemneni EC, Strawn JR, Patino LR, DelBello MP, Ramsey LB. Cariprazine in Youth with Bipolar and Psychotic Disorders: A Retrospective Chart Review. J Child Adolesc Psychopharmacol. 2020 05; 30(4):267-272.
Score: 0.689